PROCEPT BioRobotics Corporation Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PROCEPT BioRobotics Corporation (PRCT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.43 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.32M shares, a 37.81% increase year-over-year.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.04M shares, a 14.37% decline year-over-year.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 7.05M shares, a 0.69% decline year-over-year.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 7.10M shares, a 10.65% increase year-over-year.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.24M shares, a 7.12% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.83M shares, a 15.07% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.86M shares, a 10.56% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.21M shares, a 5.89% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 8.43M shares 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 8.32M shares 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | 6.24M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 6.14M shares 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 5.96M shares 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | 6.04M shares 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | 5.83M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 6.41M shares 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | 6.67M shares 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 7.05M shares 10-Q · filed 2025-05-02 | |||
| 2023-12-31 | 6.86M shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 7.11M shares 10-Q · filed 2024-10-28 | |||
| 2023-06-30 | 7.14M shares 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | 7.10M shares 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | 6.21M shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 6.11M shares 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | 6.29M shares 10-Q · filed 2023-07-28 | |||
| 2022-03-31 | 6.41M shares 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 6.59M shares 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 6.61M shares 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | 36.54M shares 10-Q · filed 2022-08-05 | |||
| 2021-03-31 | 31.92M shares 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | 31.98M shares 10-K · filed 2022-03-22 | |||
| 2020-09-30 | 31.63M shares 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |